{
    "nctId": "NCT05730010",
    "briefTitle": "Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis",
    "officialTitle": "Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis",
    "overallStatus": "COMPLETED",
    "conditions": "Triple Negative Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 289,
    "primaryOutcomeMeasure": "Examine whether knowledge of ctDNA negativity influences patient decision-making",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Self- reported history of non-metastatic breast cancer\n* Self- reported history of receiving chemotherapy for breast cancer\n* Self- reported history of chemotherapy completed at least 6 months ago but no more than 10 years ago\n* Able to complete an online survey\n* English speaking\n\nExclusion Criteria:\n\nN/A",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}